Hematology in Diabetes Mellitus; Diagnostic and Prognostic Role of Complete Blood Count and Hemogram-Derived Novel Markers in Diabetes Mellitus and Its Complications
Asian Hematology Research Journal,
Page 1-25
Abstract
Diabetes mellitus a chronic, progressive, metabolic disorder characterised by hyperglycemia initially because of tissue insulin resistance and gradually progressing to complete loss of secretory activity of the beta cells of the pancreas, most frequently caused by impaired insulin secretion, resistance to tissue actions of insulin, or a combination of both. Study of hematological changes in diabetic patients along with complete blood count(CBC), hemogram derived novel markers including Neutrophil-Lymphocyte ratio (NLR), Monocyte-Lymphocyte ratio (MLR),Red cell distribution width-Platelet ratio (RPR),Mean Platelet Volume to Lymphocyte Ratio (MPVLR) Platelet-Lymphocyte ratio (PLR) etc and its diagnostic and prognostic value in diabetes mellitus and its complications are reviewed in this literature review which may shed fresh light on developing new treatment plans on diabetic patients and help doctors in the diagnosis and prognosis of diabetic patients with or without complications, helping with diabetes early diagnosis, and early detection of long-term complications in diabetes patients, which results in improving quality of life in diabetic patients.
Keywords:
- Diabetes mellitus
- complete blood count
- hemogram; anemia
- vascular complications
How to Cite
Varghese, A., & Vaidya, K. A. (2023). Hematology in Diabetes Mellitus; Diagnostic and Prognostic Role of Complete Blood Count and Hemogram-Derived Novel Markers in Diabetes Mellitus and Its Complications. Asian Hematology Research Journal, 7(2), 1-25. Retrieved from https://journalahrj.com/index.php/AHRJ/article/view/30217
References
Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications diabetes special issue. Phys Ther. 2008;88.
Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol. 2017;8:6. DOI: 10.3389/fendo.2017.00006, PMID 28167928.
Roglic G. WHO Global report on diabetes: A summary. Int J Noncommunicable Dis. 2016;1(1):3. DOI: 10.4103/2468-8827.184853
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020; 21(17):1–34. DOI: 10.3390/ijms21176275, PMID 32872570.
Bandeira Sde M, da Fonseca LJS, Guedes Gda S, Rabelo LA, Goulart MOF, Vasconcelos SML. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14(2):3265-84. DOI: 10.3390/ijms14023265, PMID 23385234.
Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of diabetes 2017. J Diabetes Res. 2018;2018:3086167. DOI: 10.1155/2018/3086167, PMID 29713648.
Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. American Diabetes Association Inc. 2017;66(2):241-55. DOI: 10.2337/db16-0806, PMID 27980006.
Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243-52. DOI: 10.1185/03007995.2016.1168291, PMID 26986190.
Lippi G, Mercadanti M, Aloe R, Targher G. Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Eur J Intern Med. 2012;23(2):150-3. DOI: 10.1016/j.ejim.2011.11.004, PMID 22284245.
Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. North Am J Med Sci. 2011;3(7):344-7. DOI: 10.4297/najms.2011.3344, PMID 22540111.
Sahay M, Kalra S, Badani R, Bantwal G, Bhoraskar A, Das AK, et al. Diabetes and anemia: International Diabetes Federation (IDF)-Southeast Asian Region (SEAR) position statement. Diabetes Metab Syndr. 2017;11;Suppl 2:S685-95. DOI: 10.1016/j.dsx.2017.04.026, PMID 28483426.
Fiseha T, Adamu A, Tesfaye M, Gebreweld A. Prevalence of anemia in diabetic adult outpatients in Northeast Ethiopia. PLOS ONE. 2019;14(9): e0222111. DOI: 10.1371/journal.pone.0222111, PMID 31498832.
Shams N, Osmani MH. Newly diagnosed anemia in admitted diabetics, frequency, etiology and associated factors. J Coll Physicians Surg Pak. 2015;25(4):242-6. PMID 25899186.
Kim M, Lee SH, Park KS, Kim EJ, Yeo S, Ha IH. Association between diabetes mellitus and anemia among Korean adults according to sex: A cross-sectional analysis of data from the Korea National Health and Nutrition Examination Survey (2010-2016). BMC Endocr Disord. 2021;21(1):209. DOI: 10.1186/s12902-021-00873-9, PMID 34674696.
Al-Salman M. Anemia in patients with diabetes mellitus: Prevalence and progression. Gen Med. 2015;1-4.
Shabeeb MN, Siddiq A, R, BD, R, NG. A study on prevalence of type II diabetes mellitus patients with anemia in teaching hospital. Certified [journal] │ 1836 World Journal of Pharmaceutical Research SJIF Impact Factor. 2021;10(11):1836-43. DOI: 10.20959/wjpr202111-21470
Barbieri J, Fontela PC, Winkelmann ER, Zimmermann CEP, Sandri YP, Mallet EKV et al. Anemia in patients with type 2 diabetes mellitus. Anemia. 2015;2015: 354737. DOI: 10.1155/2015/354737, PMID 26640706.
Taderegew MM, Gebremariam T, Tareke AA, Woldeamanuel GG. Anemia and its associated factors among type 2 diabetes mellitus patients attending debre berhan referral hospital, north-east Ethiopia: A cross-sectional study. J Blood Med. 2020;11:47-58. DOI: 10.2147/JBM.S243234, PMID 32104127.
Hosseini MS, Rostami Z, Saadat A, Saadatmand SM, Naeimi E. Anemia and microvascular complications in patients with type 2 diabetes mellitus. Nephrourol Mon. 2014;6(4):e19976. DOI: 10.5812/numonthly.19976, PMID 25695026.
Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 2001;24(3):495-9. DOI: 10.2337/diacare.24.3.495, PMID 11289474.
Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. World J Nephrol. 2016;5(4):358-66. DOI: 10.5527/wjn.v5.i4.358, PMID 27458564.
Sari NKP, Wande IN, Suega IK, Wirawati IAP, Mahartini NN, Herawati S. The relationship between hepcidin and anemia in controlled and uncontrolled Type-2 Diabetes Mellitus (T2DM) patients at Sanglah Hospital, Bali, Indonesia. Indones J Biomed Sci. 2021;15(2):140-4. DOI: 10.15562/ijbs.v15i2.361
M Raqib T, K Polus R, S Mohammad N. Prevalence of vitamin B12 Deficiency in Patients with type 2 diabetes mellitus on metformin. Diyala J Med. 2022;23(1):22-32. DOI: 10.26505/DJM.23016480407
Lin HY, Chung CY, Chang CS, Wang ML, Lin JS, Shen MC. Hyperhomocysteinemia, deep vein thrombosis and vitamin B12 deficiency in a metformin-treated diabetic patient. J Formos Med Assoc. 2007;106(9):774-8. DOI: 10.1016/S0929-6646(08)60039-X, PMID 17908667.
Kirkiz S, Yarali N, Arman Bilir O, Tunc B. Metformin-induced hemolytic anemia. Med Princ Pract. 2014;23(2):183-5. DOI: 10.1159/000356149, PMID 24296614.
Abdel-Moneim A, Abdel-Reheim ES, Semmler M, Addaleel W. The impact of glycemic status and metformin administration on red blood cell indices and oxidative stress in type 2 diabetic patients. Malays J Med Sci. 2019;26(4):47-60. DOI: 10.21315/mjms2019.26.4.6, PMID 31496893.
Donnelly LA, Dennis JM, Coleman RL, Sattar N, Hattersley AT, Holman RR, et al. Risk of anemia with metformin use in type 2 diabetes: A mastermind study. Diabetes Care. 2020;43(10):2493-9. DOI: 10.2337/dc20-1104, PMID 32801130.
Christy AL, Manjrekar PA, Babu RP, Hegde A, Rukmini MS. Influence of iron deficiency anemia on hemoglobin A1C levels in diabetic individuals with controlled plasma glucose levels. Iran Biomed J. 2014;18(2):88-93. DOI: 10.6091/ibj.1257.2014, PMID 24518549.
Fujita Y, Doi Y, Hamano T, Hatazaki M, Umayahara Y, Isaka Y, et al. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: A prospective cohort study. Sci Rep. 2019;9(1):14871. DOI: 10.1038/s41598-019-51207-8, PMID 31619722.
Kannan S, Jaipalreddy C, Annapandian VM, Murali Mohan BV, Damodar S, Khadilkar KS, et al. Impact of anemia and red cell indices on the diagnosis of pre-diabetes and diabetes in Indian adult population: is there a cut-off guide for clinicians? Indian J Endocrinol Metab. 2019;23(1):91-6. DOI: 10.4103/ijem.IJEM_190_18, PMID 31016161.
El-Achkar TM, Ohmit SE, Mccullough PA, Crook ED, Brown WW, Grimm R, et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: the Kidney Early Evaluation Program. Kidney Int. 2005;67(4):1483-8. DOI: 10.1111/j.1523-1755.2005.00226.x, PMID 15780101.
Kurtul BE, Inal B, Altiaylik Özer P, Kabataş EU. The correlation between red cell distribution width and diabetic retinopathy in patients with type 2 diabetes mellitus. Turkiye Klinikleri J Ophthalmol. 2017;26(1): 19-24. DOI: 10.5336/ophthal.2016-50943
Engström G, Smith JG, Persson M, Nilsson PM, Melander O, Hedblad B. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med. 2014;276(2):174-83. DOI: 10.1111/joim.12188, PMID 24471821.
Al-Kindi SG, Refaat M, Jayyousi A, Asaad N, al Suwaidi J, Abi Khalil CA. Red cell distribution width is associated with All-Cause and cardiovascular mortality in patients with diabetes. BioMed Res Int. 2017;2017:5843702. DOI: 10.1155/2017/5843702, PMID 29359154.
Nada AM. Red cell distribution width in type 2 diabetic patients. Diabetes Metab Syndr Obes. 2015;8:525-33. DOI: 10.2147/DMSO.S85318, PMID 26586957.
Xanthopoulos A, Giamouzis G, Melidonis A, Kitai T, Paraskevopoulou E, Paraskevopoulou P, et al. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol. 2017; 16(1):81. DOI: 10.1186/s12933-017-0563-1, PMID 28683798.
Sherif H, Ramadan N, Radwan M, Hamdy E, Reda R. Red cell distribution width as a marker of inflammation in type 2 diabetes mellitus. Life Sci J. 2013;10(4)://www:5.
Knychala MA, Garrote-Filho MDS, Batista da Silva B, Neves de Oliveira S, Yasminy Luz S, Marques Rodrigues MO, et al. Red cell distribution width and erythrocyte osmotic stability in type 2 diabetes mellitus. J Cell Mol Med. 2021;25(5):2505-16. DOI: 10.1111/jcmm.16184, PMID 33591627.
Atalay H, Boyuk B, Ates M, Guzel S, Celebi A, Ekizoglu I. Red cell distribution width and acute complications of diabetes. Acta Endocrinol (Buchar). Acta Endocrinologica Foundation. 2018;14(4): 514-9. DOI: 10.4183/aeb.2018.514, PMID 31149305.
Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia. 2012;55(1):226-35. DOI: 10.1007/s00125-011-2331-1, PMID 22002006.
Ms J. Diabetes and red blood cell parameters. Ann Clin Endocrinol Metabol. 2017;2(1):1-9. DOI: 10.29328/journal.acem.1001004.
Samuel TR, Tejaswi N, Kumar P, Prudhvi K, Sravan NS, Govardhin B. Clinical significance of screening for anaemia in diabetic patients. Artic Int J PharmSci Rev Res. 2018;48(2):20-4.
Alamri BN, Bahabri A, Aldereihim AA, Alabduljabbar M, Alsubaie MM, Alnaqeb D, et al. Hyperglycemia effect on red blood cells indices. Eur Rev Med Pharmacol Sci. 2019;23(5):2139-50. DOI: 10.26355/EURREV_201903_17259, PMID 30915759.
Farooqui R, Afsar N, Afroze IA. Role and Significance of Hematological parameters in Diabetes Mellitus. Annals Pathol Lab Med. 2019;6(3):A158-162. DOI: 10.21276/apalm.2355
Gezawa ID, Ugwu ET, Ezeani I, Adeleye O, Okpe I, Enamino M. Anemia in patients with diabetic foot ulcer and its impact on disease outcome among Nigerians: results from the MEDFUN study. PLOS ONE. 2019;14(12):e0226226. DOI: 10.1371/journal.pone.0226226, PMID 31846473.
Kawabe A, Yasu T, Morimoto T, Tokushige A, Momomura S ichi, Sakakura K, Node K, Inoue T, Ueda S. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study. ESC Heart Failure. 2021; 8(5):3748–3759. Available:https://doi.org/10.1002/ehf2.13513
Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B, et al. White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care. 2013; 36(2):276-82. DOI: 10.2337/dc11-2298, PMID 22961572.
Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, et al. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine (United States). 2017;96(45):e8289. DOI: 10.1097/MD.0000000000008289, PMID 29137012.
Luo P, Huang Y, Xu T, Ji Y, Yu N, He L. Relationship between hyperuricemia and neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus. Int J Clin Exp Pathol. 2016;9(10):10833-8.
Vatankhah N, Jahangiri Y, Landry GJ, McLafferty RB, Alkayed NJ, Moneta GL, et al. Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing. J Vasc Surg. 2017;65(2):478-83. DOI: 10.1016/j.jvs.2016.08.108, PMID 27887858.
Lee GK, Lee LC, Chong E, Lee CH, Teo SG, Chia BL, et al. The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarction. Q J M. 2012;105(11):1075-82. DOI: 10.1093/qjmed/hcs123, PMID 22771557.
Khandare SA, Chittawar S, Nahar N, Dubey TN, Qureshi Z. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian J Endocrinol Metab. 2017;21(3): 387-92. DOI: 10.4103/ijem.IJEM_476_16, PMID 28553592.
M. N, D. J, D. K. Study of relationship between WBC count and Diabetic complications. Int J Adv Med. 2017;4(4)(4): 1128. DOI: 10.18203/2349-3933.ijam20173245.
Youssef Moursy E. Relationship between neutrophil-lymphocyte ratio and microvascular complications in Egyptian patients with Type 2 diabetes. Am J Intern Med. 2015;3(6):250. DOI: 10.11648/j.ajim.20150306.16
Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794-801. PMID 25126182.
Jaaban M, Zetoune AB, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7(7):e07564. DOI: 10.1016/j.heliyon.2021.e07564, PMID 34368476.
Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602-6. DOI: 10.4314/ahs.v19i1.35, PMID 31148989.
Sefil F, Ulutas KT, Dokuyucu R, Sumbul AT, Yengil E, Yagiz AE, et al. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014; 42(2):581-8. DOI: 10.1177/0300060513516944, PMID 24567354.
Jiang H, Yan WH, Li CJ, Wang AP, Dou JT, Mu YM. Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people. Int J Environ Res Public Health. 2014;11(5):5497-509. DOI: 10.3390/ijerph110505497, PMID 24852600.
Wan H, Wang Y, Fang S, Chen Y, Zhang W, Xia F et al. Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes: A cross-sectional study. J Diabetes Res. 2020;2020:6219545. DOI: 10.1155/2020/6219545, PMID 32405503.
Zhou D, Wang J, Li X. The platelet-lymphocyte ratio associated with depression in diabetes patients in the us national health and nutrition examination survey. Int J Gen Med. 2021;14:7825-32. DOI: 10.2147/IJGM.S334883, PMID 34795503.
Jabeen F, Fawwad A, Rizvi HA, Alvi F. Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients. Pak J Med Sci. 2013;29(1):152-6. DOI: 10.12669/pjms.291.2592, PMID 24353529.
Ali Jiskani S, Singh D, Khan M. Platelets indices as biomarkers of glycemic control and progression of complications in patients of diabetes mellitus Type II. In J Haematol Stem Cell Res. 2021;1(1).
Sincer I, Gunes Y, Inanir M. Platelet indices in type 1 diabetes mellitus. Exp Biomed Res. 2019;2(2):69-75. DOI: 10.30714/j-ebr.2019250352
Buch A, Kaur S, Nair R, Jain A. Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients. J Lab Physicians. 2017;9(2):84-8. DOI: 10.4103/0974-2727.199625, PMID 28367021.
Pujani M, Gahlawat H, Agarwal C, Chauhan V, Singh K, Lukhmana S. Platelet parameters: can they serve as biomarkers of glycemic control or development of complications in evaluation of type 2 diabetes mellitus? Iraqi J Hematol. 2018;7(2):72. DOI: 10.4103/ijh.ijh_8_18
Bhattacharjee DP, Datta DA, Debbarma DRK, Kumar Das DS. Platelet indices in diabetics and influence of glycemic control-a hospital based study in North-East India. Int J Med Res Rev. 2016;4(12):2186-92. doi: 10.17511/ijmrr.2016.i12.18.
Walinjkar RS, Khadse S, Kumar S, Bawankule S, Acharya S. Platelet indices as a predictor of microvascular complications in type 2 diabetes. Indian J Endocrinol Metab. 2019;23(2):206-10. DOI: 10.4103/ijem.IJEM_13_19, PMID 31161104.
Jindal S, Gupta S, Gupta R, Kakkar A, v. Singh HV, Gupta K, et al. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology. 2011;16(2):86-9. DOI:10.1179/102453311X12902908412110, PMID 21418738.
Kocak MZ, Aktas G, Erkus E, Duman TT, Atak BM, Savli H. Mean platelet volume to lymphocyte ratio as a novel marker for diabetic nephropathy. J Coll Physicians Surg Pak. 2018;28(11):844-7. DOI: 10.29271/jcpsp.2018.11.844, PMID 30369376.
Cakir L, Aktas G, Enginyurt OZGUR, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Med Mediterr. 2014;30(2):425-8.
Akinsegun A, Akinola Olusola DA, Sarah JO, Olajumoke O, Adewumi A, Majeed O et al. Mean platelet volume and platelet counts in type 2 Diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J. 2014;18:42. DOI: 10.11604/pamj.2014.18.42.3651, PMID 25368731.
Mardia AI, Gatot D, Lindarto D. Comparison platelet indices in diabetic patients with and without diabetic foot ulcer. IOP Conf S Earth Environ Sci. 2018;125(1). DOI: 10.1088/1755-1315/125/1/012134.
Zuberi FC, B. Pride AH, F, Z. B. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J. 2008;49(2).
Alhadas KR, Santos SN, Freitas MMS, Viana SMSA, Ribeiro LC, Costa MB. Are platelet indices useful in the evaluation of type 2 diabetic patients? J Bras Patol Med Lab. 2016;52(2):96-102. DOI: 10.5935/1676-2444.20160017
Milosevic D, Panin VL. Relationship between hematological parameters and glycemic control in type 2 diabetes mellitus patients. J Med Biochem. 2019;38(2): 164-71. DOI: 10.2478/jomb-2018-0021, PMID 30867644.
Ebrahim H, Fiseha T, Ebrahim Y, Bisetegn H. Comparison of hematological parameters between type 2 diabetes mellitus patients and healthy controls at Dessie comprehensive specialized hospital, Northeast Ethiopia: comparative cross-sectional study. PLOS ONE. 2022;17(7):e0272145. DOI: 10.1371/journal.pone.0272145, PMID 35895700.
Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016;9:91-9. DOI: 10.2147/DMSO.S97563, PMID 27042134.
Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016;9:91-9. DOI: 10.2147/DMSO.S97563, PMID 27042134.
Bilgin S, Aktas G, Zahid Kocak M, Atak BM, Kurtkulagi O, Duman TT, et al. Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. Aging Male. 2020;23(5): 923-7. DOI: 10.1080/13685538.2019.1632283, PMID 31250688.
Narjis M, Noreen M, Safi SZ, Ilahi NE, Alomar SY, Alkhuriji AF. Cross talk between complete blood count and progression of type II diabetes mellitus. J King Saud Univ Sci. 2021;33(6). DOI: 10.1016/j.jksus.2021.101492
Sargın MA, Yassa M, Taymur BD, Celik A, Ergun E, Tug N. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy? Ther Clin Risk Manag. 2016;12:657-65. DOI: 10.2147/TCRM.S104247, PMID 27217758.
Mendes BB, Oliveira ACR, de Alcântara KC. Comparison of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in normoglycemic and hyperglycemic subjects. Einstein (Sao Paulo). 2019; 17(1):eAO4403. DOI:10.31744/einstein_journal/2019AO4403, PMID 30652737.
Wang JR, Chen Z, Yang K, Yang HJ, Tao WY, Li YP, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12(1):55. DOI: 10.1186/s13098-020-00562-y, PMID 32636938.
Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras. 1992; 2019;65(1):38-42. DOI: 10.1590/1806-9282.65.1.38, PMID 30758418.
Atlı H, Onalan E, Yakar B, Duzenci D, Dönder E. Predictive value of inflammatory and hematological data in diabetic and non-diabetic retinopathy. Eur Rev Med Pharmacol Sci. 2022;26(1):76-83. DOI: 10.26355/eurrev_202201_27750, PMID 35049022.
Maruyama T, Takashima H, Oguma H, Nakamura Y, Ohno M, Utsunomiya K, et al. Canagliflozin improves erythropoiesis in diabetes patients with anemia of chronic kidney disease. Diabetes Technol Ther. 2019;21(12):713-20. DOI: 10.1089/dia.2019.0212, PMID 31385724.
Chaudhury A, Duvoor C, Reddy Dendi VS, Kraleti S, Chada A, Ravilla R, et al. Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management. Front Endocrinol. 2017;8:6. DOI: 10.3389/fendo.2017.00006, PMID 28167928.
Roglic G. WHO Global report on diabetes: A summary. Int J Noncommunicable Dis. 2016;1(1):3. DOI: 10.4103/2468-8827.184853
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020; 21(17):1–34. DOI: 10.3390/ijms21176275, PMID 32872570.
Bandeira Sde M, da Fonseca LJS, Guedes Gda S, Rabelo LA, Goulart MOF, Vasconcelos SML. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14(2):3265-84. DOI: 10.3390/ijms14023265, PMID 23385234.
Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M. Complications of diabetes 2017. J Diabetes Res. 2018;2018:3086167. DOI: 10.1155/2018/3086167, PMID 29713648.
Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. American Diabetes Association Inc. 2017;66(2):241-55. DOI: 10.2337/db16-0806, PMID 27980006.
Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243-52. DOI: 10.1185/03007995.2016.1168291, PMID 26986190.
Lippi G, Mercadanti M, Aloe R, Targher G. Erythrocyte mechanical fragility is increased in patients with type 2 diabetes. Eur J Intern Med. 2012;23(2):150-3. DOI: 10.1016/j.ejim.2011.11.004, PMID 22284245.
Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. North Am J Med Sci. 2011;3(7):344-7. DOI: 10.4297/najms.2011.3344, PMID 22540111.
Sahay M, Kalra S, Badani R, Bantwal G, Bhoraskar A, Das AK, et al. Diabetes and anemia: International Diabetes Federation (IDF)-Southeast Asian Region (SEAR) position statement. Diabetes Metab Syndr. 2017;11;Suppl 2:S685-95. DOI: 10.1016/j.dsx.2017.04.026, PMID 28483426.
Fiseha T, Adamu A, Tesfaye M, Gebreweld A. Prevalence of anemia in diabetic adult outpatients in Northeast Ethiopia. PLOS ONE. 2019;14(9): e0222111. DOI: 10.1371/journal.pone.0222111, PMID 31498832.
Shams N, Osmani MH. Newly diagnosed anemia in admitted diabetics, frequency, etiology and associated factors. J Coll Physicians Surg Pak. 2015;25(4):242-6. PMID 25899186.
Kim M, Lee SH, Park KS, Kim EJ, Yeo S, Ha IH. Association between diabetes mellitus and anemia among Korean adults according to sex: A cross-sectional analysis of data from the Korea National Health and Nutrition Examination Survey (2010-2016). BMC Endocr Disord. 2021;21(1):209. DOI: 10.1186/s12902-021-00873-9, PMID 34674696.
Al-Salman M. Anemia in patients with diabetes mellitus: Prevalence and progression. Gen Med. 2015;1-4.
Shabeeb MN, Siddiq A, R, BD, R, NG. A study on prevalence of type II diabetes mellitus patients with anemia in teaching hospital. Certified [journal] │ 1836 World Journal of Pharmaceutical Research SJIF Impact Factor. 2021;10(11):1836-43. DOI: 10.20959/wjpr202111-21470
Barbieri J, Fontela PC, Winkelmann ER, Zimmermann CEP, Sandri YP, Mallet EKV et al. Anemia in patients with type 2 diabetes mellitus. Anemia. 2015;2015: 354737. DOI: 10.1155/2015/354737, PMID 26640706.
Taderegew MM, Gebremariam T, Tareke AA, Woldeamanuel GG. Anemia and its associated factors among type 2 diabetes mellitus patients attending debre berhan referral hospital, north-east Ethiopia: A cross-sectional study. J Blood Med. 2020;11:47-58. DOI: 10.2147/JBM.S243234, PMID 32104127.
Hosseini MS, Rostami Z, Saadat A, Saadatmand SM, Naeimi E. Anemia and microvascular complications in patients with type 2 diabetes mellitus. Nephrourol Mon. 2014;6(4):e19976. DOI: 10.5812/numonthly.19976, PMID 25695026.
Bosman DR, Winkler AS, Marsden JT, Macdougall IC, Watkins PJ. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 2001;24(3):495-9. DOI: 10.2337/diacare.24.3.495, PMID 11289474.
Loutradis C, Skodra A, Georgianos P, Tolika P, Alexandrou D, Avdelidou A, et al. Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study. World J Nephrol. 2016;5(4):358-66. DOI: 10.5527/wjn.v5.i4.358, PMID 27458564.
Sari NKP, Wande IN, Suega IK, Wirawati IAP, Mahartini NN, Herawati S. The relationship between hepcidin and anemia in controlled and uncontrolled Type-2 Diabetes Mellitus (T2DM) patients at Sanglah Hospital, Bali, Indonesia. Indones J Biomed Sci. 2021;15(2):140-4. DOI: 10.15562/ijbs.v15i2.361
M Raqib T, K Polus R, S Mohammad N. Prevalence of vitamin B12 Deficiency in Patients with type 2 diabetes mellitus on metformin. Diyala J Med. 2022;23(1):22-32. DOI: 10.26505/DJM.23016480407
Lin HY, Chung CY, Chang CS, Wang ML, Lin JS, Shen MC. Hyperhomocysteinemia, deep vein thrombosis and vitamin B12 deficiency in a metformin-treated diabetic patient. J Formos Med Assoc. 2007;106(9):774-8. DOI: 10.1016/S0929-6646(08)60039-X, PMID 17908667.
Kirkiz S, Yarali N, Arman Bilir O, Tunc B. Metformin-induced hemolytic anemia. Med Princ Pract. 2014;23(2):183-5. DOI: 10.1159/000356149, PMID 24296614.
Abdel-Moneim A, Abdel-Reheim ES, Semmler M, Addaleel W. The impact of glycemic status and metformin administration on red blood cell indices and oxidative stress in type 2 diabetic patients. Malays J Med Sci. 2019;26(4):47-60. DOI: 10.21315/mjms2019.26.4.6, PMID 31496893.
Donnelly LA, Dennis JM, Coleman RL, Sattar N, Hattersley AT, Holman RR, et al. Risk of anemia with metformin use in type 2 diabetes: A mastermind study. Diabetes Care. 2020;43(10):2493-9. DOI: 10.2337/dc20-1104, PMID 32801130.
Christy AL, Manjrekar PA, Babu RP, Hegde A, Rukmini MS. Influence of iron deficiency anemia on hemoglobin A1C levels in diabetic individuals with controlled plasma glucose levels. Iran Biomed J. 2014;18(2):88-93. DOI: 10.6091/ibj.1257.2014, PMID 24518549.
Fujita Y, Doi Y, Hamano T, Hatazaki M, Umayahara Y, Isaka Y, et al. Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: A prospective cohort study. Sci Rep. 2019;9(1):14871. DOI: 10.1038/s41598-019-51207-8, PMID 31619722.
Kannan S, Jaipalreddy C, Annapandian VM, Murali Mohan BV, Damodar S, Khadilkar KS, et al. Impact of anemia and red cell indices on the diagnosis of pre-diabetes and diabetes in Indian adult population: is there a cut-off guide for clinicians? Indian J Endocrinol Metab. 2019;23(1):91-6. DOI: 10.4103/ijem.IJEM_190_18, PMID 31016161.
El-Achkar TM, Ohmit SE, Mccullough PA, Crook ED, Brown WW, Grimm R, et al. Higher prevalence of anemia with diabetes mellitus in moderate kidney insufficiency: the Kidney Early Evaluation Program. Kidney Int. 2005;67(4):1483-8. DOI: 10.1111/j.1523-1755.2005.00226.x, PMID 15780101.
Kurtul BE, Inal B, Altiaylik Özer P, Kabataş EU. The correlation between red cell distribution width and diabetic retinopathy in patients with type 2 diabetes mellitus. Turkiye Klinikleri J Ophthalmol. 2017;26(1): 19-24. DOI: 10.5336/ophthal.2016-50943
Engström G, Smith JG, Persson M, Nilsson PM, Melander O, Hedblad B. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med. 2014;276(2):174-83. DOI: 10.1111/joim.12188, PMID 24471821.
Al-Kindi SG, Refaat M, Jayyousi A, Asaad N, al Suwaidi J, Abi Khalil CA. Red cell distribution width is associated with All-Cause and cardiovascular mortality in patients with diabetes. BioMed Res Int. 2017;2017:5843702. DOI: 10.1155/2017/5843702, PMID 29359154.
Nada AM. Red cell distribution width in type 2 diabetic patients. Diabetes Metab Syndr Obes. 2015;8:525-33. DOI: 10.2147/DMSO.S85318, PMID 26586957.
Xanthopoulos A, Giamouzis G, Melidonis A, Kitai T, Paraskevopoulou E, Paraskevopoulou P, et al. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol. 2017; 16(1):81. DOI: 10.1186/s12933-017-0563-1, PMID 28683798.
Sherif H, Ramadan N, Radwan M, Hamdy E, Reda R. Red cell distribution width as a marker of inflammation in type 2 diabetes mellitus. Life Sci J. 2013;10(4)://www:5.
Knychala MA, Garrote-Filho MDS, Batista da Silva B, Neves de Oliveira S, Yasminy Luz S, Marques Rodrigues MO, et al. Red cell distribution width and erythrocyte osmotic stability in type 2 diabetes mellitus. J Cell Mol Med. 2021;25(5):2505-16. DOI: 10.1111/jcmm.16184, PMID 33591627.
Atalay H, Boyuk B, Ates M, Guzel S, Celebi A, Ekizoglu I. Red cell distribution width and acute complications of diabetes. Acta Endocrinol (Buchar). Acta Endocrinologica Foundation. 2018;14(4): 514-9. DOI: 10.4183/aeb.2018.514, PMID 31149305.
Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia. 2012;55(1):226-35. DOI: 10.1007/s00125-011-2331-1, PMID 22002006.
Ms J. Diabetes and red blood cell parameters. Ann Clin Endocrinol Metabol. 2017;2(1):1-9. DOI: 10.29328/journal.acem.1001004.
Samuel TR, Tejaswi N, Kumar P, Prudhvi K, Sravan NS, Govardhin B. Clinical significance of screening for anaemia in diabetic patients. Artic Int J PharmSci Rev Res. 2018;48(2):20-4.
Alamri BN, Bahabri A, Aldereihim AA, Alabduljabbar M, Alsubaie MM, Alnaqeb D, et al. Hyperglycemia effect on red blood cells indices. Eur Rev Med Pharmacol Sci. 2019;23(5):2139-50. DOI: 10.26355/EURREV_201903_17259, PMID 30915759.
Farooqui R, Afsar N, Afroze IA. Role and Significance of Hematological parameters in Diabetes Mellitus. Annals Pathol Lab Med. 2019;6(3):A158-162. DOI: 10.21276/apalm.2355
Gezawa ID, Ugwu ET, Ezeani I, Adeleye O, Okpe I, Enamino M. Anemia in patients with diabetic foot ulcer and its impact on disease outcome among Nigerians: results from the MEDFUN study. PLOS ONE. 2019;14(12):e0226226. DOI: 10.1371/journal.pone.0226226, PMID 31846473.
Kawabe A, Yasu T, Morimoto T, Tokushige A, Momomura S ichi, Sakakura K, Node K, Inoue T, Ueda S. WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study. ESC Heart Failure. 2021; 8(5):3748–3759. Available:https://doi.org/10.1002/ehf2.13513
Twig G, Afek A, Shamiss A, Derazne E, Tzur D, Gordon B, et al. White blood cells count and incidence of type 2 diabetes in young men. Diabetes Care. 2013; 36(2):276-82. DOI: 10.2337/dc11-2298, PMID 22961572.
Xu T, Weng Z, Pei C, Yu S, Chen Y, Guo W, et al. The relationship between neutrophil-to-lymphocyte ratio and diabetic peripheral neuropathy in type 2 diabetes mellitus. Medicine (United States). 2017;96(45):e8289. DOI: 10.1097/MD.0000000000008289, PMID 29137012.
Luo P, Huang Y, Xu T, Ji Y, Yu N, He L. Relationship between hyperuricemia and neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus. Int J Clin Exp Pathol. 2016;9(10):10833-8.
Vatankhah N, Jahangiri Y, Landry GJ, McLafferty RB, Alkayed NJ, Moneta GL, et al. Predictive value of neutrophil-to-lymphocyte ratio in diabetic wound healing. J Vasc Surg. 2017;65(2):478-83. DOI: 10.1016/j.jvs.2016.08.108, PMID 27887858.
Lee GK, Lee LC, Chong E, Lee CH, Teo SG, Chia BL, et al. The long-term predictive value of the neutrophil-to-lymphocyte ratio in Type 2 diabetic patients presenting with acute myocardial infarction. Q J M. 2012;105(11):1075-82. DOI: 10.1093/qjmed/hcs123, PMID 22771557.
Khandare SA, Chittawar S, Nahar N, Dubey TN, Qureshi Z. Study of neutrophil-lymphocyte ratio as novel marker for diabetic nephropathy in type 2 diabetes. Indian J Endocrinol Metab. 2017;21(3): 387-92. DOI: 10.4103/ijem.IJEM_476_16, PMID 28553592.
M. N, D. J, D. K. Study of relationship between WBC count and Diabetic complications. Int J Adv Med. 2017;4(4)(4): 1128. DOI: 10.18203/2349-3933.ijam20173245.
Youssef Moursy E. Relationship between neutrophil-lymphocyte ratio and microvascular complications in Egyptian patients with Type 2 diabetes. Am J Intern Med. 2015;3(6):250. DOI: 10.11648/j.ajim.20150306.16
Akbas EM, Demirtas L, Ozcicek A, Timuroglu A, Bakirci EM, Hamur H, et al. Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy. Int J Clin Exp Med. 2014;7(7):1794-801. PMID 25126182.
Jaaban M, Zetoune AB, Hesenow S, Hessenow R. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as novel risk markers for diabetic nephropathy in patients with type 2 diabetes. Heliyon. 2021;7(7):e07564. DOI: 10.1016/j.heliyon.2021.e07564, PMID 34368476.
Duman TT, Aktas G, Atak BM, Kocak MZ, Erkus E, Savli H. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602-6. DOI: 10.4314/ahs.v19i1.35, PMID 31148989.
Sefil F, Ulutas KT, Dokuyucu R, Sumbul AT, Yengil E, Yagiz AE, et al. Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus. J Int Med Res. 2014; 42(2):581-8. DOI: 10.1177/0300060513516944, PMID 24567354.
Jiang H, Yan WH, Li CJ, Wang AP, Dou JT, Mu YM. Elevated white blood cell count is associated with higher risk of glucose metabolism disorders in middle-aged and elderly Chinese people. Int J Environ Res Public Health. 2014;11(5):5497-509. DOI: 10.3390/ijerph110505497, PMID 24852600.
Wan H, Wang Y, Fang S, Chen Y, Zhang W, Xia F et al. Associations between the neutrophil-to-lymphocyte ratio and diabetic complications in adults with diabetes: A cross-sectional study. J Diabetes Res. 2020;2020:6219545. DOI: 10.1155/2020/6219545, PMID 32405503.
Zhou D, Wang J, Li X. The platelet-lymphocyte ratio associated with depression in diabetes patients in the us national health and nutrition examination survey. Int J Gen Med. 2021;14:7825-32. DOI: 10.2147/IJGM.S334883, PMID 34795503.
Jabeen F, Fawwad A, Rizvi HA, Alvi F. Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients. Pak J Med Sci. 2013;29(1):152-6. DOI: 10.12669/pjms.291.2592, PMID 24353529.
Ali Jiskani S, Singh D, Khan M. Platelets indices as biomarkers of glycemic control and progression of complications in patients of diabetes mellitus Type II. In J Haematol Stem Cell Res. 2021;1(1).
Sincer I, Gunes Y, Inanir M. Platelet indices in type 1 diabetes mellitus. Exp Biomed Res. 2019;2(2):69-75. DOI: 10.30714/j-ebr.2019250352
Buch A, Kaur S, Nair R, Jain A. Platelet volume indices as predictive biomarkers for diabetic complications in Type 2 diabetic patients. J Lab Physicians. 2017;9(2):84-8. DOI: 10.4103/0974-2727.199625, PMID 28367021.
Pujani M, Gahlawat H, Agarwal C, Chauhan V, Singh K, Lukhmana S. Platelet parameters: can they serve as biomarkers of glycemic control or development of complications in evaluation of type 2 diabetes mellitus? Iraqi J Hematol. 2018;7(2):72. DOI: 10.4103/ijh.ijh_8_18
Bhattacharjee DP, Datta DA, Debbarma DRK, Kumar Das DS. Platelet indices in diabetics and influence of glycemic control-a hospital based study in North-East India. Int J Med Res Rev. 2016;4(12):2186-92. doi: 10.17511/ijmrr.2016.i12.18.
Walinjkar RS, Khadse S, Kumar S, Bawankule S, Acharya S. Platelet indices as a predictor of microvascular complications in type 2 diabetes. Indian J Endocrinol Metab. 2019;23(2):206-10. DOI: 10.4103/ijem.IJEM_13_19, PMID 31161104.
Jindal S, Gupta S, Gupta R, Kakkar A, v. Singh HV, Gupta K, et al. Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications. Hematology. 2011;16(2):86-9. DOI:10.1179/102453311X12902908412110, PMID 21418738.
Kocak MZ, Aktas G, Erkus E, Duman TT, Atak BM, Savli H. Mean platelet volume to lymphocyte ratio as a novel marker for diabetic nephropathy. J Coll Physicians Surg Pak. 2018;28(11):844-7. DOI: 10.29271/jcpsp.2018.11.844, PMID 30369376.
Cakir L, Aktas G, Enginyurt OZGUR, Cakir SA. Mean platelet volume increases in type 2 diabetes mellitus independent of HbA1c level. Acta Med Mediterr. 2014;30(2):425-8.
Akinsegun A, Akinola Olusola DA, Sarah JO, Olajumoke O, Adewumi A, Majeed O et al. Mean platelet volume and platelet counts in type 2 Diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria. Pan Afr Med J. 2014;18:42. DOI: 10.11604/pamj.2014.18.42.3651, PMID 25368731.
Mardia AI, Gatot D, Lindarto D. Comparison platelet indices in diabetic patients with and without diabetic foot ulcer. IOP Conf S Earth Environ Sci. 2018;125(1). DOI: 10.1088/1755-1315/125/1/012134.
Zuberi FC, B. Pride AH, F, Z. B. Comparison of mean platelet volume in patients with diabetes mellitus, impaired fasting glucose and non-diabetic subjects. Singapore Med J. 2008;49(2).
Alhadas KR, Santos SN, Freitas MMS, Viana SMSA, Ribeiro LC, Costa MB. Are platelet indices useful in the evaluation of type 2 diabetic patients? J Bras Patol Med Lab. 2016;52(2):96-102. DOI: 10.5935/1676-2444.20160017
Milosevic D, Panin VL. Relationship between hematological parameters and glycemic control in type 2 diabetes mellitus patients. J Med Biochem. 2019;38(2): 164-71. DOI: 10.2478/jomb-2018-0021, PMID 30867644.
Ebrahim H, Fiseha T, Ebrahim Y, Bisetegn H. Comparison of hematological parameters between type 2 diabetes mellitus patients and healthy controls at Dessie comprehensive specialized hospital, Northeast Ethiopia: comparative cross-sectional study. PLOS ONE. 2022;17(7):e0272145. DOI: 10.1371/journal.pone.0272145, PMID 35895700.
Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016;9:91-9. DOI: 10.2147/DMSO.S97563, PMID 27042134.
Biadgo B, Melku M, Abebe SM, Abebe M. Hematological indices and their correlation with fasting blood glucose level and anthropometric measurements in type 2 diabetes mellitus patients in Gondar, Northwest Ethiopia. Diabetes Metab Syndr Obes. 2016;9:91-9. DOI: 10.2147/DMSO.S97563, PMID 27042134.
Bilgin S, Aktas G, Zahid Kocak M, Atak BM, Kurtkulagi O, Duman TT, et al. Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men. Aging Male. 2020;23(5): 923-7. DOI: 10.1080/13685538.2019.1632283, PMID 31250688.
Narjis M, Noreen M, Safi SZ, Ilahi NE, Alomar SY, Alkhuriji AF. Cross talk between complete blood count and progression of type II diabetes mellitus. J King Saud Univ Sci. 2021;33(6). DOI: 10.1016/j.jksus.2021.101492
Sargın MA, Yassa M, Taymur BD, Celik A, Ergun E, Tug N. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy? Ther Clin Risk Manag. 2016;12:657-65. DOI: 10.2147/TCRM.S104247, PMID 27217758.
Mendes BB, Oliveira ACR, de Alcântara KC. Comparison of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in normoglycemic and hyperglycemic subjects. Einstein (Sao Paulo). 2019; 17(1):eAO4403. DOI:10.31744/einstein_journal/2019AO4403, PMID 30652737.
Wang JR, Chen Z, Yang K, Yang HJ, Tao WY, Li YP, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history. Diabetol Metab Syndr. 2020;12(1):55. DOI: 10.1186/s13098-020-00562-y, PMID 32636938.
Atak B, Aktas G, Duman TT, Erkus E, Kocak MZ, Savli H. Diabetes control could through platelet-to-lymphocyte ratio in hemograms. Rev Assoc Med Bras. 1992; 2019;65(1):38-42. DOI: 10.1590/1806-9282.65.1.38, PMID 30758418.
Atlı H, Onalan E, Yakar B, Duzenci D, Dönder E. Predictive value of inflammatory and hematological data in diabetic and non-diabetic retinopathy. Eur Rev Med Pharmacol Sci. 2022;26(1):76-83. DOI: 10.26355/eurrev_202201_27750, PMID 35049022.
Maruyama T, Takashima H, Oguma H, Nakamura Y, Ohno M, Utsunomiya K, et al. Canagliflozin improves erythropoiesis in diabetes patients with anemia of chronic kidney disease. Diabetes Technol Ther. 2019;21(12):713-20. DOI: 10.1089/dia.2019.0212, PMID 31385724.
-
Abstract View: 44 times
PDF Download: 19 times
Download Statistics
Downloads
Download data is not yet available.
